Portage Biotech (PRTG) Earnings Date & Reports

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PRTG is expected to report earnings to fall 88.30% to -21 cents per share on August 15

Portage Biotech PRTG Stock Earnings Reports

Q1'24

Est.

$-0.22

Q4'23

Missed

by $1.61

Q3'23

Missed

by $0.02

Q2'23

Missed

by $0.95

Q1'23

Missed

by $5.07

The last earnings report on February 28 showed earnings per share of -187 cents, missing the estimate of -27 cents. With 4.78K shares outstanding, the current market capitalization sits at 7.32M.

View a ticker or compare two or three

Compare

PRTG